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Abstract: Diffuse idiopathic skeletal hyperostosis
(DISH) is an ossifying systemic enthesopathy which
involves not only the spine but which may also appear in
other sites. Degenerative, inflammatory and metabolic
factors have been reported for a possible pathogenic role
in the new bone growth that characterises DISH. In the
present study peripheral bone mineral density (BMD)
has been measured in patients affected by DISH and the
results compared to those of a control group. Forty-two
patients (33 females and 9 males) affected by DISH and
84 controls (66 females and 18 males) were examined.
All subjects underwent radiological study of the lumbar
and dorsal spine and the pelvis. BMD was evaluated
using dual-energy X-ray absorptiometry and the exam-
ination was performed in the distal radius. In DISH
patients the mean value of BMD was significantly higher
than in controls (P50.002), even when it was referred to
sex subgroups. Statistical analysis showed significant
differences between both the two male groups
(P50.002) and the two female groups (P50.01). In
the two female subgroups (DISH patients and controls)
BMD was significantly inversely related to age and to
the duration of the postmenopausal period. The present
study showed higher BMD in DISH patients than in the
control group.
Keywords: Bone mineral density; Diffuse idiopathic
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Introduction
Diffuse idiopathic skeletal hyperostosis (DISH) is an
ossifying systemic enthesopathy which involves the
ligaments, tendons at their bone insertions, capsules
and the anulus fibrosus of the intervertebral discs.
Hyperostosis typically involves the spine, but may also
appear in other sites [1,2]. Its aetiology is unknown.
There are many hypotheses as to the possible role of
various pathogenic factors: degenerative, inflammatory
and metabolic (relationship with mellitus diabetes)
factors have all been reported in early studies [3–5].
The presence of local osteogenic hyperactivity has been
already suggested [6]. More recently it has been
suggested that systemic metabolic factors may be
involved in the new bone growth that characterises the
disease. On the other hand, the presence of such systemic
factors has been hypothesised also in primary osteo-
arthritis (OA); in fact, increased skeletal concentrations
of insulin-like growth factor I, insulin-like growth factor
II and transforming growth factor b have been
considered as possible mechanisms that increase bone
density in OA [7]. Although DISH is often considered to
be a variant of OA, diarthrodial joints are not involved,
intervertebral joints spaces are preserved and apophyseal
joints appear to be normal. On the other hand, DISH
shows some similarities with OA: for instance, a
particular type of hyperostotic hip OA with a remarkable
construction has been shown to be associated with DISH
[8].
Some studies [9] have reported increased values of
bone mineral density (BMD) in OA with respect to
osteoporosis (OP). The same result was found when
comparing patients with OA to normal subjects [10,11].
This finding may be justified by the presence of different
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pathogenic factors that affect bone mass, confirming the
already reported inverse association between the risk of
OA and that of OP [12].
To our knowledge, only certain authors [18] have
studied bone mineral density (BMD) in DISH patients
with respect to controls without finding any significant
difference in BMD between the two groups. For this
reason we investigated the relationship between DISH
and BMD and the results were compared to age- and sex-
matched healthy controls. We also evaluated calcium-
phosphorus changes in both DISH patients and controls.
Methods
A total of 42 consecutive caucasian patients affected by
DISH were studied after giving their informed consent.
The diagnosis of DISH was made according to
Utsinger’s criteria of 1985 [13]. The subjects were 33
females (mean age 63.6 ± 7.3 years, range 48–77; mean
time since menopause 159.2 ± 91.4 months, range 12–
372) and 9 males (mean age 64.3 ± 6.4 years; range 51–
73). Eighty-four healthy caucasian subjects were studied
as a control group, randomly selected from the general
population. These were 66 females (mean age 63.0 ± 6.8
years, range 47–77; mean time since menopause 148.3 ±
65.1 months, range 12–324) and 18 males (mean age
64.5 ± 6.8 years, range 51–77), and were matched with
our patients’ sex, age and time since menopause (Table
1). In the female subgroups the time since menopause
showed no statistical difference. The two groups (DISH
patients and healthy subjects) had a similar type of
physical activity, which was light or moderate in all
cases, and body mass index values that were without
statistical significance. Both the DISH and the healthy
groups had no history of fractures secondary to
osteoporosis, and no drugs known to alter bone
metabolism had been taken. Seven of the DISH patients
were affected by diabetes mellitus type II; three of them
were treated with diet and four with oral anti-diabetic
drugs. In the control group the subjects with sympto-
matic OA were excluded from the study. Renal function
was normal in both groups.
A further 19 females (mean age 60.8 ± 6.7 years,
range 48–70; mean time since menopause 128.2 ± 82.2
months, range 12–264) and 9 males (mean age 63 ± 6.4
years, range 51–73) with normal BMD values were
selected from among the DISH groups.
We then selected 24 females (mean age 59.6 ± 6.8
years, range 47–75; mean time since menopause 110.6 ±
68.7 months, range 12–324) and 16 males (mean age
63.3 ± 6.5 years, range 51–73) with normal BMD values
from among the healthy groups, matching them with our
patients’ sex, ages and time since menopause; the age
and time since menopause showed no statistically
significant difference between the two groups.
All of our subjects underwent dorsolumbar and pelvic
radiographs (anteroposterior and lateral) and dual X-ray
absorptiometry of the non-dominant forearm.
Bone Mineral Density
BMD was studied using dual-energy X-ray absorptio-
metry (DEXA), with dedicated software for the study of
the upper extremities (TURBOSCAN–DEXA Nim). The
examinations were performed in the distal radius of the
non-dominant forearm (Fig. 1). The precision error was
0.7% and the reproducibility error was 0.5%. The normal
value of BMD, at distal radius level, was more than 336
Fig. 1. Radius level of measurement (TURBOSCAN-DEXA Nim).
Table 1. Characteristics of study groups
DISH Controls
Number of cases 42 84
Males/females 9/33 18/66
Age (years; mean ± SD) (min/max) 63.8 ±7.0 (48/77)* 63.4 ± 6.8 (47/77)*
Age males (years; mean ± SD) (min/max) 64.3 ± 6.4 (51/73)* 64.5 ± 6.8 (51/77)*
Age females (years; mean ± SD) (min/max) 63.6 ± 7.3 (48/77)* 63 ± 6.8 (47/77)*
Time since menopause (months; mean ± SD) 159.2 ± 91.4* 148.3 ± 65.1*
Time since menopause (months; min/max) 12/372* 12/324*
Body mass index (males/females) 27.0 ± 0.2/26.8 ± 2.0* 27.4 ± 1.7/26.7 ± 2.6*
*P value = NS (Wilcoxon uncoupled test).
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g/cm2 and 341 g/cm2 respectively for the female and
male groups. All measurements were performed by the
same operator.
Biochemical Measurements
After an overnight fast blood and 24-hour urine
specimens were obtained for the determination of
serum calcium (Ca), phosphorus (P), alkaline phospha-
tase (ALP), osteocalcin (OC) and urine hydroxyproline
(OH-Pro). Fasting blood was collected from each subject
between 09:00 and 09:30 a.m. Samples were stored at
–70 8C before measurement. Serum measurements were
performed using the following methods: total Ca
concentration by colorimetric photometry; inorganic P
by ultraviolet photometry; ALP by enzymatic colori-
metry; and OC by radioimmunoassay. Urine Ca and OH-
Pro were all tested by means of colorimetric photometry
after 3 days of diet without collagen and standard
calcium intake (Table 2).
Statisticala Analysis
Wilcoxon’s uncoupled data analysis was performed to
assess the difference between groups. Spearman’s rank
correlation test was performed to determine whether any
correlation existed. Data are presented as mean ±
standard deviation (SD) and range.
The data for all patients were entered on a PC into a
Statgraphics database (STSC Inc., USA).
Results
The dorsolumbar and pelvic radiographs demonstrated
the absence of any deformity or fracture of the vertebral
bodies and the pelvis in both groups (patients and
healthy subjects).
Among the 33 females with DISH we found that BMD
correlated negatively with age (r = –0.5280, P50.003)
and months since menopause (r = –0.3933, P50.03).
Among the 66 healthy female subjects BMD also
correlated negatively with age (r = –0.4689, P50.0002)
and months since menopause (r = –0.4946, P50.0001).
In the two male groups (DISH patients and controls)
BMD did not correlate with age.
We found that DISH patients had higher mean BMD
values than did the control group (401.2 ± 100.5 g/cm2
vs 341.8 ± 74.2 g/cm2; P50.002); in particular, the 33
female DISH patients had higher mean BMD values than
the female controls (363.8 ± 69.8 g/cm2 vs 324.2 ± 60.8
g/cm2; P50.01) (Table 3). The 9 DISH males also had
higher average BMD than healthy male subjects (538.5 ±
72.9 g/cm2 vs 402.1 ± 85.7 g/cm2; P50.002). To
evaluate the statistical significance between the DISH
and the control groups with normal BMD values (more
than 336 g/cm2 for the females and 341 g/cm2 for the
males) we carried out the Wilcoxon test for uncoupled
data and found that the DISH males had a higher average
BMD than healthy subjects (538.5 ± 72.9 g/cm2 vs 428.2
± 59.8 g/cm2; P50.003), as did the DISH females
(412.8 ± 43.3 g/cm2 vs 384.5 ± 40.6 g/cm2; P50.02).
We found no significant difference in serum Ca, P,
ALP, OC and urine OH-Pro between DISH patients and
controls.
Table 2. Results of biochemical measurements
DISH Controls Normal values P value*
Ca 9.1 ± 0.5 9.3 ± 0.6 8.6–10.6 mg/dl NS
P 3.7 ± 0.4 3.6 ± 0.3 3.0–4.5 mg/dl NS
Ur. Ca 216.5 ± 25.6 219.5 ± 26.2 100–300 mg/24h NS
ALP 122.1 ± 22.9 121 ± 23.3 50–190 U/l NS
OC 8.9 ± 1.4 9 ± 1.3 2–14 ng/ml NS
OHpr. 11.7 ± 4.5 11.9 ± 2 6–22 mg/24h/m2 NS
*Wilcoxon uncoupled test.
Table 3. Results of BMD measurement
No.
DISH/Contr.
DISH Controls P value*
BMD in all males 9 18 538.5 ± 72.9 402.1 ± 85.7 < 0.002
BMD in all females 33 66 363.8 ± 69.8 324.2 ± 60.8 < 0.01
BMD in males with normal values** 9 16 538.5 ± 72.9 428.2 ± 59.8 < 0.003
BMD in females with normal values** 19 24 412.8 ± 43.3 384.5 ± 40.6 < 0.02
BMD (g/cm2): mean ± SD; measured at distal radius.
*Wilcoxon uncoupled test.
** Subgroups whose data are included in the normal values of the technique used for the measurement of BMD (n.v.: for males: more than 341
g/cm2; for females: more than 336 g/cm2).
190 M. Di Franco et al.
Discussion
Our study showed significant higher BMD in DISH
patients than in controls, and the mean value of BMD
was higher in both male and female patients with DISH.
Also, when we considered patients and control subjects
with normal BMD values we found significantly higher
BMD in DISH patients.
We chose to measure BMD at the distal radius to
avoid overestimation, because this site is not usually
involved in OA and DISH. Some studies have shown
that the measurement of BMD at the distal radius
(representing predominantly trabecular bone) was sig-
nificantly higher than at proximal level (representing
predominantly cortical bone) in women with OA
[14,15]; this finding could be partly explained by the
higher metabolic activity in trabecular bone [16].
However, another study showed increased BMD in
women with OA at both cortical and trabecular sites in
the radius [17].
To our knowledge, before our study only Troillet et al.
[18] measured BMD in DISH patients and in healthy
controls, but they found no significant difference in
BMD between the two groups. In contrast, for the first
time we have shown higher BMD in DISH patients than
in controls. This could be explained by the dissimilar
characteristics of the groups (higher number of females
in our study); by the different sizes of the study groups;
or by the different techniques used to measure BMD.
In a case report other authors [19] showed high-
turnover osteoporosis in a patient with DISH and
superficial bladder cancer. Therefore, in this case the
coexistence of DISH and OP was probably influenced
both by the underlying disease and the therapy, even
though the relationship between DISH and OP has not so
far been investigated.
Instead, many studies have been performed concern-
ing OA and BMD. In recent reports [11] densitometric
physical and histomorphometric analysis of bone
samples taken from iliac crest in patients affected by
OA showed high BMD. The findings showed the global
skeletal involvement in OA, being the changes present
not only at the affected joints but also in other articular
areas. More recent studies have confirmed these findings
[20–22].
The Rotterdam Study [23] showed that BMD was
higher in patients with OA and the rate of bone loss was
increased in men and women with OA of the knee and
the hips; moreover, the age-related bone loss ratio was
increased in older patients, suggesting a more pro-
nounced difference in BMD earlier in the life. These
findings suggest the presence of metabolic factors that
may play an important role in BMD and bone loss ratio.
At present, the problem of the inverse relationship
between OA and OP has not yet been solved. In fact,
other authors have not found increased BMD in OA [24–
26]. The different results probably depend on the lack of
homogeneity between the groups, i.e. the dissimilar
modalities of patient and control group selection, such as
sex, age, postmenopausal period duration, body mass
index, contemporary presence of other diseases and
previous therapy. In fact, all these factors act on bone
mass and may consequently modify BMD. The different
results obtained by the various authors may also depend
on the method of studying BMD.
The present study seems to suggest a bone involve-
ment in DISH. Some reports [27] have already high-
lighted the presence of subchondral osteitis as one of the
first changes of the disease. Similar results have been
reported in some studies by Resnick and Niwayama [28]
and Bonucci [29]. Other studies showed a higher
presence of bone growth factors in patients with DISH,
and suggested a possible relevant role for those
substances in the pathogenesis of the disease [30]. The
finding may be confirmed by the presence of hyper-
ostosis in some disorders with a high production of
growth factors [7]. In fact, DISH is a diffuse systemic
condition in which it is likely that both mechanical and
local factors act on the propensity to deposit new bone.
Moreover, it seems likely that systemic metabolic factors
also have a role in the new bone growth that is
characteristic of the disease [30].
In conclusion, to the best of our knowledge, the
present study has for the first time shown higher BMD in
DISH patients than in a healthy control group. These
results need to be confirmed by additional studies with
larger groups.
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